Elite health systems CEO buys $2,250 in common stock

Published 02/05/2025, 20:36
Elite health systems CEO buys $2,250 in common stock

ONTARIO, CA—In a recent transaction, Prasad Anjaneya Jeereddi, CEO and Director of Elite Health Systems Inc. (USNU), acquired 3,000 shares of the company’s common stock. The purchase, made on May 1, 2025, was executed at a price of $0.75 per share, totaling $2,250. The acquisition comes amid a notable 17% decline in the stock price over the past week, with shares currently trading at $0.69. According to InvestingPro analysis, the company appears overvalued at current levels, despite maintaining strong liquidity with a current ratio of 45.2.

Following this transaction, Jeereddi directly owns 1,531,983 shares. Additionally, he indirectly holds 222,114 shares through an entity where he is a managing member and major equity owner, as noted in the filing. This acquisition reflects Jeereddi’s continued investment in Elite Health Systems, a company known for its innovative health solutions. With a market capitalization of $14.77 million, Elite Health Systems faces profitability challenges, reporting a loss per share of $0.13 over the last twelve months. InvestingPro subscribers can access additional insights, including 7 more key investment tips and comprehensive insider trading analysis.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.